Safety evaluation of remdesivir administration in patients with severe renal impairment and coronavirus disease: a systematic review and meta-analysis

Abstract Background We conducted a comprehensive systematic review and meta-analysis to evaluate whether remdesivir (RDV) is safe for patients with severe renal impairment (SRI) and COVID-19, compared to non-SRI patients or those not receiving RDV. Methods This study was conducted according to the P...

Full description

Bibliographic Details

Published in:	BMC Infectious Diseases
Main Authors:	Takumi Umemura, Hideo Kato, Yoshikazu Mutoh, Mao Hagihara, Yoshiaki Ikeda, Hiroshige Mikamo
Format:	Article
Language:	English
Published:	BMC 2025-06-01
Subjects:	Remdesivir Renal impairment SARS-CoV-2
Online Access:	https://doi.org/10.1186/s12879-025-11153-5